{"id":50216,"date":"2022-10-28T14:02:01","date_gmt":"2022-10-28T12:02:01","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/harrow-to-announce-third-quarter-2022-financial-results-on-november-14-2022\/"},"modified":"2022-10-28T14:02:01","modified_gmt":"2022-10-28T12:02:01","slug":"harrow-to-announce-third-quarter-2022-financial-results-on-november-14-2022","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/harrow-to-announce-third-quarter-2022-financial-results-on-november-14-2022\/","title":{"rendered":"Harrow to Announce Third Quarter 2022 Financial Results on November 14, 2022"},"content":{"rendered":"
\n

NASHVILLE–(BUSINESS WIRE)–Harrow (Nasdaq: HROW), an eyecare pharmaceutical company exclusively focused on the discovery, development, and commercialization of innovative ophthalmic therapies, today announced that it will release its financial results for the third quarter ended September 30, 2022, on Monday, November 14, 2022, after the market close. The Company will also post its third quarter Letter to Stockholders to the \u201cInvestors\u201d section of its website, harrowinc.com<\/a>. Harrow will host a conference call and live webcast at 4:45 p.m. Eastern Time to discuss the results and provide a business update.\n<\/p>\n

<\/a><\/p>\n\n\n\n\n\n\n\n
\n

\nConference Call Details:<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nDate:<\/b>\n<\/p>\n<\/td>\n

\n

\nMonday, November 14, 2022\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nTime:<\/b>\n<\/p>\n<\/td>\n

\n

\n4:45 p.m. Eastern time\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nParticipant Dial-in:<\/b>\n<\/p>\n<\/td>\n

\n

\n1-833-953-2434 (U.S.)
\n
1-412-317-5763 (International)\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nReplay Dial-in (Passcode 7735845):<\/b>\n<\/p>\n

\n(telephonic replay through November 21, 2022)<\/i><\/b>\n<\/p>\n<\/td>\n

\n

\n1-877-344-7529 (U.S.)
\n
1-412-317-0088 (International)\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nWebcast: (online replay through February 14, 2023)<\/i><\/b>\n<\/p>\n<\/td>\n

\n

\nharrowinc.com<\/a>\n<\/p>\n<\/td>\n<\/tr>\n<\/table>\n

\nAbout Harrow<\/b>\n<\/p>\n

\nHarrow (Nasdaq: HROW) is an eyecare pharmaceutical company exclusively focused on the discovery, development, and commercialization of innovative ophthalmic therapies that are accessible and affordable. For more information about Harrow, including investor-related materials, please visit the corporate website, harrowinc.com<\/a>, or Harrow\u2019s LinkedIn<\/a> page.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nJamie Webb, Director of Communications and Investor Relations
\n
jwebb@harrowinc.com<\/a>
615-733-4737\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

NASHVILLE–(BUSINESS WIRE)–Harrow (Nasdaq: HROW), an eyecare pharmaceutical company exclusively focused on the discovery, development, and commercialization of innovative ophthalmic therapies, today announced that it will release its financial results for the third quarter ended September 30, 2022, on Monday, November 14, 2022, after the market close. The Company will also post its third quarter Letter … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-50216","6":"format-standard","7":"category-industry"},"yoast_head":"\nHarrow to Announce Third Quarter 2022 Financial Results on November 14, 2022 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/harrow-to-announce-third-quarter-2022-financial-results-on-november-14-2022\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Harrow to Announce Third Quarter 2022 Financial Results on November 14, 2022 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"NASHVILLE–(BUSINESS WIRE)–Harrow (Nasdaq: HROW), an eyecare pharmaceutical company exclusively focused on the discovery, development, and commercialization of innovative ophthalmic therapies, today announced that it will release its financial results for the third quarter ended September 30, 2022, on Monday, November 14, 2022, after the market close. The Company will also post its third quarter Letter ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/harrow-to-announce-third-quarter-2022-financial-results-on-november-14-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-28T12:02:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221027005179\/en\/1533746\/21\/Harrow_logo_wTag.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/harrow-to-announce-third-quarter-2022-financial-results-on-november-14-2022\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/harrow-to-announce-third-quarter-2022-financial-results-on-november-14-2022\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Harrow to Announce Third Quarter 2022 Financial Results on November 14, 2022\",\"datePublished\":\"2022-10-28T12:02:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/harrow-to-announce-third-quarter-2022-financial-results-on-november-14-2022\\\/\"},\"wordCount\":202,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/harrow-to-announce-third-quarter-2022-financial-results-on-november-14-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221027005179\\\/en\\\/1533746\\\/21\\\/Harrow_logo_wTag.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/harrow-to-announce-third-quarter-2022-financial-results-on-november-14-2022\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/harrow-to-announce-third-quarter-2022-financial-results-on-november-14-2022\\\/\",\"name\":\"Harrow to Announce Third Quarter 2022 Financial Results on November 14, 2022 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/harrow-to-announce-third-quarter-2022-financial-results-on-november-14-2022\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/harrow-to-announce-third-quarter-2022-financial-results-on-november-14-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221027005179\\\/en\\\/1533746\\\/21\\\/Harrow_logo_wTag.jpg\",\"datePublished\":\"2022-10-28T12:02:01+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/harrow-to-announce-third-quarter-2022-financial-results-on-november-14-2022\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/harrow-to-announce-third-quarter-2022-financial-results-on-november-14-2022\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/harrow-to-announce-third-quarter-2022-financial-results-on-november-14-2022\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221027005179\\\/en\\\/1533746\\\/21\\\/Harrow_logo_wTag.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221027005179\\\/en\\\/1533746\\\/21\\\/Harrow_logo_wTag.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/harrow-to-announce-third-quarter-2022-financial-results-on-november-14-2022\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Harrow to Announce Third Quarter 2022 Financial Results on November 14, 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Harrow to Announce Third Quarter 2022 Financial Results on November 14, 2022 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/harrow-to-announce-third-quarter-2022-financial-results-on-november-14-2022\/","og_locale":"en_US","og_type":"article","og_title":"Harrow to Announce Third Quarter 2022 Financial Results on November 14, 2022 - Pharma Trend","og_description":"NASHVILLE–(BUSINESS WIRE)–Harrow (Nasdaq: HROW), an eyecare pharmaceutical company exclusively focused on the discovery, development, and commercialization of innovative ophthalmic therapies, today announced that it will release its financial results for the third quarter ended September 30, 2022, on Monday, November 14, 2022, after the market close. The Company will also post its third quarter Letter ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/harrow-to-announce-third-quarter-2022-financial-results-on-november-14-2022\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-28T12:02:01+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221027005179\/en\/1533746\/21\/Harrow_logo_wTag.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/harrow-to-announce-third-quarter-2022-financial-results-on-november-14-2022\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/harrow-to-announce-third-quarter-2022-financial-results-on-november-14-2022\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Harrow to Announce Third Quarter 2022 Financial Results on November 14, 2022","datePublished":"2022-10-28T12:02:01+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/harrow-to-announce-third-quarter-2022-financial-results-on-november-14-2022\/"},"wordCount":202,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/harrow-to-announce-third-quarter-2022-financial-results-on-november-14-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221027005179\/en\/1533746\/21\/Harrow_logo_wTag.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/harrow-to-announce-third-quarter-2022-financial-results-on-november-14-2022\/","url":"https:\/\/pharma-trend.com\/en\/harrow-to-announce-third-quarter-2022-financial-results-on-november-14-2022\/","name":"Harrow to Announce Third Quarter 2022 Financial Results on November 14, 2022 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/harrow-to-announce-third-quarter-2022-financial-results-on-november-14-2022\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/harrow-to-announce-third-quarter-2022-financial-results-on-november-14-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221027005179\/en\/1533746\/21\/Harrow_logo_wTag.jpg","datePublished":"2022-10-28T12:02:01+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/harrow-to-announce-third-quarter-2022-financial-results-on-november-14-2022\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/harrow-to-announce-third-quarter-2022-financial-results-on-november-14-2022\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/harrow-to-announce-third-quarter-2022-financial-results-on-november-14-2022\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221027005179\/en\/1533746\/21\/Harrow_logo_wTag.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221027005179\/en\/1533746\/21\/Harrow_logo_wTag.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/harrow-to-announce-third-quarter-2022-financial-results-on-november-14-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Harrow to Announce Third Quarter 2022 Financial Results on November 14, 2022"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50216","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=50216"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50216\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=50216"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=50216"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=50216"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}